We have previously shown that Gch1 expression is a key determinant of BH4 bioavailability, eNOS regulation, and NO generation.1,2 Evidence from experimental and clinical studies have demonstrated that reduced BH4 bioavailability is associated with the pathogenesis of endothelial dysfunction, a hallmark of vascular disease states. This evidence concerns the gene GCH1 and endothelial dysfunction.